Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure.
about
Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational ModificationsThrombocytopenia associated with dialysis treatments.Biochemistry, physiology, and complications of blood doping: facts and speculation.Are biosimilars really generics?Biopharmaceutical benchmarks 2006.Pure red cell aplasia caused by ribavirin and interferon treatment.
P2860
Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@ast
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@en
type
label
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@ast
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@en
prefLabel
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@ast
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@en
P2860
P1433
P1476
Acquired red cell aplasia in a ...... etin in chronic renal failure.
@en
P2093
Lay-Cheng Lim
P2860
P304
P356
10.1080/10245330400026154
P577
2005-06-01T00:00:00Z